• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Stocks

Can Abbott Labs Get Its Act Together?

Traders finally seem to be rejecting the downside of ABT.
By BRUCE KAMICH
Oct 13, 2021 | 02:44 PM EDT
Stocks quotes in this article: ABT

Abbott Laboratories (ABT) is scheduled to report its third-quarter numbers on Oct. 20, so let's check and see if this fundamental news could shake ABT out of the technical doldrums.

In the daily Japanese candlestick chart of ABT, below, we can see that the shares have declined the past five weeks or so. ABT broke below the rising 200-day moving average line and now prices are testing the underside of this longer-term indicator. A close back above the line will be a positive development.

The On-Balance-Volume (OBV) weakened in September and shows some improvement this month. The Moving Average Convergence Divergence (MACD) oscillator looks ready to cross to a cover shorts buy signal.

In the weekly Japanese candlestick chart of ABT, below, we can see two recent lower shadows suggesting to us that traders are finally rejecting the downside of ABT.

The weekly OBV line shows improvement and the MACD oscillator needs further strength.

In this daily Point and Figure chart of ABT, below, we can see a potential upside price target in the $175 area.

Bottom-line strategy: I have no special information about what ABT may report next week but the charts suggest you shouldn't be too bearish ahead of the report.

(Abbott Labs is a holding in the Action Alerts PLUS member club. Want to be alerted before AAP buys or sells ABT? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Pharmaceuticals | Earnings Preview

More from Stocks

You Bet Your BP I'd Be a Buyer

Mark Sebastian
Aug 16, 2022 2:32 PM EDT

With oil down over the last two days, BP's stock has held up.

Doug Kass: We May Now Be Approaching Another Important Top in the Market

Doug Kass
Aug 16, 2022 1:30 PM EDT

To justify buying at today's prices means that one expects a new Bull Market leg - something I remain dubious of.

Cisco, Long a Steady Tech Stock, Is Under the Microscope Ahead of Earnings

Brad Ginesin
Aug 16, 2022 12:45 PM EDT

Some top analysts are flashing a yellow light on the network equipment maker ahead of its quarterly report and amid tightening competition. But is caution really warranted for long-term investors?

This Market Needs Some Corrective Action

James "Rev Shark" DePorre
Aug 16, 2022 11:18 AM EDT

It's likely to occur on a rolling basis and won't be that evident in the senior indexes.

Let's Build on Home Depot's Earnings With a Trade Idea

Stephen Guilfoyle
Aug 16, 2022 10:15 AM EDT

The numbers from the home improvement retailer were decent and its outlook is OK, so here's a play involving stock and options.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:23 PM EDT STEPHEN GUILFOYLE

    We're Cleaning Out This Retailer From the Bullpen

    Check out the latest moves in TheStreet's Stocks U...
  • 10:24 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    To Improve Your Trading and Investing, Spend More ...
  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login